Study Identifies Duke Researchers as Top Cited in Past 20 Years for Immunotherapy for Glioma

By Carol Harbers

A new study of advancements in immunotherapy for glioma analyzed the 100 most cited papers of the past 20 yrs and concluded Duke researchers had made the biggest impact in the field.

The authors of the paper, published January 12, 2024 in Frontiers in Oncology, wrote:

The United States possessed a robust global presence, leading in terms of publications and maintaining strong collaborative ties with numerous countries. The institution that made the greatest contributions was Duke University, with 16 papers. Amy Heimberger, MD, John H. Sampson, MD, PhD, and David Reardon, MD, secured the top three positions with 15, 12, and 11 papers, respectively.

The authors further concluded that, " 'Macrophage ontogeny,' 'microglia,' 'polarization,' 'mass cytometry,' 'tumor mutation burden,' 'sensitivity,' 'msh6,' 'pd-1 blockade,' and 'dna repair' were the recent hot keywords. 'Microglia' and 'polarization' as the emerging research directions should be given more consideration."